By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Five Prime Therapeutics, Inc. 

1650 Owens Street
Suite 200
San Francisco  California  94158  U.S.A.
Phone: 415-365-5600 Fax: 415-365-5601


SEARCH JOBS








Company News
Five Prime Therapeutics, Inc. (FPRX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014 12:12:53 PM
Five Prime Therapeutics, Inc. (FPRX) Initiates Patient Dosing In Phase 1 Clinical Trial Evaluating FPA144 In Gastric Cancer 12/5/2014 9:50:43 AM
Five Prime Therapeutics, Inc. (FPRX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/26/2014 10:51:17 AM
Bristol-Myers Squibb Company (BMY) And Five Prime Therapeutics, Inc. (FPRX) Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types 11/24/2014 8:44:55 AM
Five Prime Therapeutics, Inc. (FPRX) Initiates Dosing Of Rheumatoid Arthritis Patients In Its Phase 1 Clinical Trial Of FPA008 11/17/2014 4:21:24 PM
Five Prime Therapeutics, Inc. (FPRX) To Present Data From Healthy Volunteer Cohorts In Phase 1 Trial Of FPA008 At The 2014 American College of Rheumatology/ARHP Annual Scientific Meeting 11/14/2014 7:22:05 AM
Five Prime Therapeutics, Inc. (FPRX) Announces Third Quarter 2014 Financial Results 11/11/2014 8:07:22 AM
Five Prime Therapeutics, Inc. (FPRX) Announces Presentation At The 2014 Society For Immunotherapy Of Cancer Annual Meeting 11/6/2014 8:23:19 AM
Five Prime Therapeutics, Inc. (FPRX) To Announce Third Quarter 2014 Financial Results And Host Conference Call On November 10 11/4/2014 7:52:38 AM
Five Prime Therapeutics, Inc. (FPRX) Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline (GSK) 10/24/2014 6:26:24 AM
12345678
//-->